CIK 0001571934
- Non-accelerated filer
- Smaller reporting company
TAO Synergies Inc.
Sign in to watch- Ticker
- TAOX
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461585656
- Phone
- +1 973-242-0005
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Synaptogenix, Inc., NEUROTROPE BIOSCIENCE, INC.
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 45,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Grant or award Alkon Daniel L. acquired 80,000 shares (grant or award)
- 4 Grant or award Director acquired 90,000 shares (grant or award)
- 3/A Insider 3/A
- 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $8.26 ($82,600)
- 4 Open-market buy Director bought 10,000 shares at $8.30 ($83,000)
Page 4 of 5 · 88 filings